73346-79-9

73346-79-9 structure

Name: Lithium mupirocin
Chemical Name: lithium,9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoate
CAS Number: 73346-79-9
Molecular Formula: C₂₆H₄₃LiO₉
Molecular Weight: 506.56
Catalog: Signaling Pathways Anti-infection Bacterial
Create Date: 2018-09-19 17:09:53
Modify Date: 2026-06-30 17:36:42
Mupirocin (BRL-4910A) lithium is an orally active antibiotic isolated from Pseudomonas fluorescens. Mupirocin lithium apparently exerts its antimicrobial activity by reversibly inhibiting isoleucyl-transfer RNA, thereby inhibiting bacterial protein and RNA synthesis[1][2][3][4][5].

Name	lithium,9-[(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[[(2S,3S)-3-[(2S,3S)-3-hydroxybutan-2-yl]oxiran-2-yl]methyl]oxan-2-yl]-3-methylbut-2-enoyl]oxynonanoate
Synonyms	Mupirocin lithium standd moxonidine impurity standd MUPIROCIN LITHIUM H0C176926UG/MG(AI) Pseudomonic Acid (lithium salt) 5,9-anhydro-2,3,4,8-tetradeoxy-8-[[(2S,3S)-3-[(1S,2S)-2-hydroxy-1-methylpropyl]-2-oxiranyl]methyl]-3-methyl-L-talo-Non-2-enonic acid 8-cboxyoctyl ester lithium salt Lithium mupirocin Supplement Lithium mupirocin solution 9-((E)-4-{(2S,3R,4R,5S)-3,4-Dihydroxy-5-[(2S,3S)-3-((1S,2S)-2-hydroxy-1-methyl-propyl)oxiranylmethyl]tetrahydro-pyran-2-yl}-3-methyl-but-2-enoyloxy)nonanoic acid lithium salt Mupirocin lithium CRS MG(AI) LITHIUM MUPIROCIN = (HPLC) Mupirocin Lithium Li-MUP Lithium pseudomonate MUPIROCIN LITHIUM H0C MUPIROCIN LITHIUM SALT Pseudomonic acid A lithium salt Lithium 9-(((E)-4-((2S,3R,4R,5S)-3,4-dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-hydroxybutan-2-yl)oxiran-2-yl)methyl)tetrahydro-2H-pyran-2-yl)-3-methylbut-2-enoyl)oxy)nonanoate Mupirocin Lithium(M3806000) Mupirocin LithiumQ: What is Mupirocin Lithium Q: What is the CAS Number of Mupirocin Lithium Q: What is the storage condition of Mupirocin Lithium

Description	Mupirocin (BRL-4910A) lithium is an orally active antibiotic isolated from Pseudomonas fluorescens. Mupirocin lithium apparently exerts its antimicrobial activity by reversibly inhibiting isoleucyl-transfer RNA, thereby inhibiting bacterial protein and RNA synthesis[1][2][3][4][5].
Related Catalog	Research Areas >> Infection Signaling Pathways >> Anti-infection >> Bacterial
References	[1]. Sutherland R, et al. Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use. Antimicrob Agents Chemother. 1985 Apr;27(4):495-8. [2]. Parenti MA, et al. Mupirocin: a topical antibiotic with a unique structure and mechanism of action. Clin Pharm. 1987 Oct;6(10):761-70. [3]. Vingsbo Lundberg C, et al. Efficacy of topical and systemic antibiotic treatment of meticillin-resistant Staphylococcus aureus in a murine superficial skin wound infection model. Int J Antimicrob Agents. 2013 Sep. 42(3):272-5.

RIDADR	NONH for all modes of transport